SecBot SecBot
S-4425 ·Filed Sep 14, 2026

MMED

MiniMed Group, Inc.
NEUTRAL
Impact 6/10
Horizonweeks Processed2mo ago SEC0001628280-26-061669
Actionable Insight • Neutral

Monitor the exchange ratio during the averaging period (Oct 5-7, 2026) as it will determine the final value for tendering shareholders. The upper limit of 4.5939 shares per Medtronic share could reduce the effective discount if MiniMed's stock price declines relative to Medtronic's. Post-exchange, focus on MiniMed's standalone execution, particularly its ability to grow CGM attachment rates and achieve profitability, as the company will no longer be supported by Medtronic's balance sheet.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$21.97
T+0 close · Sep 14, 2026 · via day close
Latest settled
−14.43%
T+20 · $18.80 · next T+60 in 21d
Vs SPY
−16.69%
α at T+20
Latest observation
−15.11%
T+44 · FF3 residual α
  1. T+0 · Sep 14 $21.97entry
  2. T+1 · 2mo ago +0.18%α +0.64% · $22.01
  3. T+5 · 8w ago −3.87%α −3.98% · $21.12
  4. T+20 · 5w ago −14.43%α −16.69% · $18.80
  5. T+45 · todayOpen
  6. T+60 · in 21d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Medtronic plc is offering to exchange up to 225,361,295 newly issued shares of MiniMed common stock for outstanding Medtronic ordinary shares at a 7% discount to MiniMed's three-day VWAP, subject to an upper limit of 4.5939 MiniMed shares per Medtronic share. The exchange offer is the primary mechanism for Medtronic's tax-efficient divestiture of its ~89.86% stake in MiniMed, creating an independent diabetes-focused company. The filing also includes MiniMed's financials showing strong 16.6% revenue growth in the latest quarter, driven by international sales and new product launches, though the company remains unprofitable on a GAAP basis.

Key Facts

  • Medtronic is offering to exchange up to 225,361,295 newly issued MiniMed shares for outstanding Medtronic ordinary shares.
  • The exchange ratio offers a 7% discount to MiniMed's three-day VWAP, subject to an upper limit of 4.5939 MiniMed shares per Medtronic share.
  • The exchange offer expires on October 9, 2026, unless extended.
  • Medtronic currently owns approximately 89.86% of MiniMed's outstanding shares.
  • MiniMed reported net sales of $843 million for the three months ended July 31, 2026, a 16.6% increase year-over-year.
  • MiniMed reported a net loss of $317 million for the fiscal year ended April 24, 2026.
  • The exchange offer is conditioned on, among other things, the receipt of a tax opinion from Skadden, Arps, Slate, Meagher & Flom LLP.
  • If the exchange offer is oversubscribed, Medtronic may accept an additional number of shares up to 2% of outstanding Medtronic ordinary shares.
  • Following the exchange offer, Medtronic intends to divest any remaining MiniMed stake through a spin-off, split-off, or debt-for-equity exchange.
  • MiniMed's unaudited pro forma net loss per share for fiscal year 2026 was $(1.29).

Financial Impact

Medtronic expects to recognize a pre-tax gain of approximately $1.7 billion on the exchange offer, assuming full subscription and the upper limit is in effect. MiniMed's unaudited pro forma net loss for fiscal year 2026 was $362 million.

revenuenet incomedilutiondebt

Risk Factors

  • The exchange offer may not be fully subscribed, leaving Medtronic as a controlling shareholder and limiting MiniMed's independence.
  • The upper limit on the exchange ratio could reduce the value received by tendering shareholders.
  • MiniMed faces significant operational risks including sole-supplier dependencies, manufacturing scale-up challenges for Simplera CGMs, and ongoing product liability litigation.
  • The tax-free treatment of the exchange offer is subject to a legal opinion and could be challenged by the IRS, potentially creating significant tax liabilities.
  • A substantial number of MiniMed shares will enter the market, potentially depressing the stock price.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
89% bullish (18 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 16 SEC documents filed with EDGAR.

DocumentAccession Number
S-4 Filing (MMED), Batch item 10001628280-26-061669
Document: minimed-exhibit992xsx4.htm0001628280-26-061673
Document: minimed-exhibit991xsx4.htm0001628280-26-061669
Document: minimed-exhibit82xsx4.htm0001628280-26-061669
Document: minimed-exhibit993xsx4.htm0001628280-26-061669
Document: minimed-exhibit995xsx4.htm0001628280-26-061669
Document: minimed-exhibit996xsx4.htm0001628280-26-061669
Document: mmedfilingfee.htm0001628280-26-061669
Document: minimed-exhibit81xsx4.htm0001628280-26-061669
Document: minimed-exhibit997xsx4.htm0001628280-26-061669
Document: minimed-exhibit994xsx4.htm0001628280-26-061669
Document: minimed-exhibit51xsx4.htm0001628280-26-061669
Document: minimed-exhibit241xsx4.htm0001628280-26-061669
Document: minimed-exhibit232xsx4.htm0001628280-26-061669
Document: minimed-exhibit231xsx4.htm0001628280-26-061669
Document: 0001628280-26-061669-index-headers.html0001628280-26-061669

Track record

25 reports on MMED

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today 8-K Mixed 6/10 Entry $18.77 Now $18.65 −0.64% settles Dec 15
  2. Nov 16, 2026today Press Release Bullish 7/10 Entry $18.81 Now $18.65 −0.86% settles Dec 15
  3. Nov 6, 202610d ago SC 13G Neutral 4/10 Entry $16.71 Now $18.65 +11.61% settles Dec 7
  4. Oct 22, 202625d ago SC 13G Neutral 4/10 Entry $18.34 Now $18.65 +1.69% settles Nov 20
  5. Oct 16, 20264w ago SC 13G/A Neutral 4/10 Entry $17.79 to $18.65 Now $18.65 +4.83% ▲ +4.83% +8.30% vs SPY
  6. Oct 16, 20264w ago 8-K Neutral 6/10 Entry $17.49 to $17.99 Now $18.65 +6.63% ▲ +2.86% +4.02% vs SPY
  7. Oct 6, 20265w ago EFFECT Neutral 3/10 Entry $19.64 to $18.85 Now $18.65 −5.04% ▼ −4.02% −0.85% vs SPY
  8. Oct 1, 20266w ago 3 Neutral 2/10 Entry $19.70 to $18.28 Now $18.65 −5.33% ▼ −7.21% −5.40% vs SPY
  9. Sep 14, 20269w ago 425 Neutral 4/10 Entry $21.97 to $18.80 Now $18.65 −15.11% ▼ −14.43% −16.69% vs SPY
  10. Sep 14, 20269w ago 425 Neutral 4/10 Entry $21.97 to $18.80 Now $18.65 −15.11% ▼ −14.43% −16.69% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens Wed (10h 22m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 14, 2026